CLINICAL ROLE -
Clinical Insights: Erlotinib for Advanced Pancreatic Cancer
Erlotinib taken with gemcitabine was approved by the FDA for locally advanced, inoperable, or metastatic pancreatic cancer in 2005.
Effects of COVID-19 on Home Infusion
Many companies are working with health systems to transition patients from the hospital to in-home care as quickly as possible.
2 Clarke Drive Cranbury, NJ 08512